Published in Malar J on November 28, 2012
Is Plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis. PLoS Negl Trop Dis (2014) 1.10
Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti. Malar J (2013) 0.90
Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia. Malar J (2016) 0.79
Serological markers to measure recent changes in malaria at population level in Cambodia. Malar J (2016) 0.78
Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran. Malar J (2016) 0.76
Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient. Malar J (2016) 0.75
Acquisition of natural humoral immunity to P. falciparum in early life in Benin: impact of clinical, environmental and host factors. Sci Rep (2016) 0.75
Proximity to vector breeding site and risk of Plasmodium vivax infection: a prospective cohort study in rural Ethiopia. Malar J (2017) 0.75
The impact of confounder selection criteria on effect estimation. Am J Epidemiol (1989) 13.34
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis (2009) 5.73
Ranking of elimination feasibility between malaria-endemic countries. Lancet (2010) 4.05
Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol (1998) 3.66
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol (2009) 1.96
Urban malaria and associated risk factors in Jimma town, south-west Ethiopia. Malar J (2011) 1.52
Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence. Am J Trop Med Hyg (1995) 1.21
Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect Immun (1998) 1.16
Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti. BMC Infect Dis (2011) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
[Plasmodium falciparum travels by train from Ethiopia to Djibouti]. Med Trop (Mars) (1991) 0.97
Malaria epidemic and drug resistance, Djibouti. Emerg Infect Dis (2005) 0.96
[The question of endemic malaria in Republic of Djibouti (author's transl)]. Med Trop (Mars) (1979) 0.91
Recurrence and emergence of infectious diseases in Djibouti city. Bull World Health Organ (1995) 0.91
Fever prevalence and management among three rural communities in the North West Zone, Somalia. East Mediterr Health J (2010) 0.85
Epidemiology and genetic characterization of HIV-1 isolates in the general population of Djibouti (Horn of Africa). J Acquir Immune Defic Syndr (2005) 0.81
Malaria in the Republic of Djibouti, 1998-2009. Am J Trop Med Hyg (2011) 0.81
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42
Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis (2012) 4.44
Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg (2002) 3.78
Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Côte d'Ivoire. Am J Trop Med Hyg (2005) 2.89
Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet (2006) 2.77
Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J (2009) 2.76
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
Combating malaria in Africa. Trends Parasitol (2002) 1.98
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg (2006) 1.97
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol (2006) 1.74
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect (2007) 1.63
Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J (2011) 1.63
Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Malar J (2010) 1.59
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother (2009) 1.59
Social and environmental malaria risk factors in urban areas of Ouagadougou, Burkina Faso. Malar J (2009) 1.57
Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006. Am J Trop Med Hyg (2007) 1.55
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J (2011) 1.40
Circulation of Chikungunya virus in Gabon, 2006-2007. J Med Virol (2008) 1.40
Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors (2011) 1.39
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg (2006) 1.35
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother (2007) 1.33
Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria. PLoS One (2012) 1.33
Comparative performances, under laboratory conditions, of seven pyrethroid insecticides used for impregnation of mosquito nets. Bull World Health Organ (2003) 1.33
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Malaria incidence in relation to rice cultivation in the irrigated Sahel of Mali. Acta Trop (2004) 1.25
Molecular detection of Bartonella quintana, B. Elizabethae, B. Koehlerae, B. Doshiae, B. Taylorii, and Rickettsia felis in rodent fleas collected in Kabul, Afghanistan. Am J Trop Med Hyg (2006) 1.24
Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J (2013) 1.23
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. J Antimicrob Chemother (2005) 1.23
Possible autochthonous malaria from Marseille to Minneapolis. Emerg Infect Dis (2007) 1.22
The use of remotely sensed environmental data in the study of malaria. Geospat Health (2011) 1.22
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother (2011) 1.19
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J (2010) 1.19
Utilization of combined remote sensing techniques to detect environmental variables influencing malaria vector densities in rural West Africa. Int J Health Geogr (2012) 1.18
Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers. J Infect Dis (2010) 1.18
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother (2013) 1.15
Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg (2006) 1.13
Artesunate tolerance in transgenic Plasmodium falciparum parasites overexpressing a tryptophan-rich protein. Antimicrob Agents Chemother (2011) 1.12
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob Agents Chemother (2011) 1.10
Diagnostic criteria and risk factors for Plasmodium ovale malaria. J Infect Dis (2002) 1.10
Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.10
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2009) 1.10
Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg (2011) 1.10
Antimalarial drug use in general populations of tropical Africa. Malar J (2008) 1.09
Chloroquine resistance reversal agents as promising antimalarial drugs. Curr Drug Targets (2006) 1.09
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08